174 related articles for article (PubMed ID: 32489478)
1. Do Higher Radiation Doses with Concurrent Chemotherapy in the Definitive Treatment of Esophageal Cancer Improve Outcomes? A Meta-Analysis and Systematic Review.
Xiao L; Czito BG; Pang Q; Hui Z; Jing S; Shan B; Wang J
J Cancer; 2020; 11(15):4605-4613. PubMed ID: 32489478
[No Abstract] [Full Text] [Related]
2. High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis of randomized clinical trials.
Wang X; Bai H; Li R; Wang L; Zhang W; Liang J; Yuan Z
Radiother Oncol; 2023 Mar; 180():109463. PubMed ID: 36642387
[TBL] [Abstract][Full Text] [Related]
3. The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis.
Luo D; Zhong Q; Zhu X
Cancer Biol Ther; 2023 Dec; 24(1):1-10. PubMed ID: 36519807
[TBL] [Abstract][Full Text] [Related]
4. High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis.
Sun X; Wang L; Wang Y; Kang J; Jiang W; Men Y; Hui Z
Front Oncol; 2020; 10():1222. PubMed ID: 32850362
[No Abstract] [Full Text] [Related]
5. Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
Koh HK; Park Y; Koo T; Park HJ; Lee MY; Chang AR; Hong S; Bae H
Anticancer Res; 2020 Mar; 40(3):1771-1778. PubMed ID: 32132086
[TBL] [Abstract][Full Text] [Related]
6. Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis.
Luo HS; Huang HC; Lin LX
Radiat Oncol; 2019 Oct; 14(1):178. PubMed ID: 31623639
[TBL] [Abstract][Full Text] [Related]
7. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
9. Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.
Brower JV; Chen S; Bassetti MF; Yu M; Harari PM; Ritter MA; Baschnagel AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):985-993. PubMed ID: 27869098
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.
Zhao L; Zhou Y; Pan H; Yin Y; Chai G; Mu Y; Xiao F; Lin SH; Shi M
J Cancer; 2017; 8(16):3242-3250. PubMed ID: 29158796
[No Abstract] [Full Text] [Related]
11. [A multicenter randomized prospective study of concurrent chemoradiation with 60 Gy versus 50 Gy for inoperable esophageal squamous cell carcinoma].
Xu YJ; Zhu WG; Liao ZX; Kong Y; Wang WW; Li JC; Huang R; He H; Yang XM; Liu LP; Sun ZW; He HJ; Bao Y; Zeng M; Pu J; Hu WY; Ma J; Jiang H; Liu ZG; Zhuang TT; Tan BX; Du XH; Qiu GQ; Zhou X; Ji YL; Hu X; Wang J; Ma HL; Zheng X; Huang J; Liu AW; Liang XD; Tao H; Zhou JY; Liu Y; Chen M
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(23):1783-1788. PubMed ID: 32536123
[No Abstract] [Full Text] [Related]
12. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
[TBL] [Abstract][Full Text] [Related]
15. High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: A systematic review and meta-analysis.
Yao Y; Lu J; Qin Z; Li N; Ma J; Yao N; Qu W; Cui L; Yuan S; Jiang A; Liu X
Radiother Oncol; 2023 Jul; 184():109700. PubMed ID: 37169302
[TBL] [Abstract][Full Text] [Related]
16. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
Cheng N; Liu Y; Zhao G; Xu Y; Zhang T; Chen Y; Yan G; Hu Y; Yao S; Wang Z; Wang C; Chen Z; Hu Z; Liu D; Chen T
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):340-348. PubMed ID: 31655197
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
18. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma.
He L; Allen PK; Potter A; Wang J; Chang JY; Gomez DR; Komaki R; Liao Z; Lin SH
J Thorac Oncol; 2014 Sep; 9(9):1398-405. PubMed ID: 25122435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
